Among them, GUCA2A, VIP, and OXTR have been demonstrated to be significantly associated with the prognosis of colon cancer (Zhang et al., 2019; Houxi Xu et al., 2020; Kang Lin et al., 2020; Zhang et al., 2020). Here, VIP is linked to colonic neoplasm.